Medistim ASA
OSE:MEDI
Medistim ASA
Total Assets
Medistim ASA
Total Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medistim ASA
OSE:MEDI
|
Total Assets
kr575m
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Lifecare AS
OSE:LIFE
|
Total Assets
kr86.4m
|
CAGR 3-Years
81%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
O
|
Observe Medical ASA
OSE:OBSRV
|
Total Assets
kr253.5m
|
CAGR 3-Years
42%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
Medistim ASA
Glance View
Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The firm provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.
See Also
What is Medistim ASA's Total Assets?
Total Assets
575m
NOK
Based on the financial report for Dec 31, 2024, Medistim ASA's Total Assets amounts to 575m NOK.
What is Medistim ASA's Total Assets growth rate?
Total Assets CAGR 10Y
11%
Over the last year, the Total Assets growth was 14%. The average annual Total Assets growth rates for Medistim ASA have been 13% over the past three years , 11% over the past five years , and 11% over the past ten years .
You don't have any saved screeners yet